Global L-Histidine Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Tablet, Capsule, Fluids, and Others

By Grade;

Pharmaceutical Grade, Food Grade, Feed Grade

By Source;

Fermentation-Based L-Histidine, Synthetic L-Histidine

By Application;

Pharmaceutical Industry, Biotechnological Industry, and Medical Industry

By Distribution Channel;

Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others

By End-Users;

Hospitals, Specialty Clinics, Ambulatory Surgical Centres, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn119165527 Published Date: May, 2025 Updated Date: June, 2025

L-Histidine Market Overview

L-Histidine Market (USD Million)

L-Histidine Market was valued at USD 709.93 million in the year 2024. The size of this market is expected to increase to USD 1,137.68 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.0%.


Global L-Histidine Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 7.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.0 %
Market Size (2024)USD 709.93 Million
Market Size (2031)USD 1,137.68 Million
Market ConcentrationMedium
Report Pages377
709.93
2024
1,137.68
2031

Major Players

  • Angene Chemicals
  • Abi Chemicals
  • Acron Pharma
  • Ajimomoto
  • Changzhou Highassay Chemical Co. Ltd
  • Huaheng Biologgical
  • My Protein
  • Twin Labs

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global L-Histidine Market

Fragmented - Highly competitive market without dominant players


L-Histidine Market is experiencing sustained growth, primarily driven by its indispensable role in human health and its increasing adoption across diverse sectors. As an essential amino acid, L-histidine supports critical biological functions, including enzyme activity, immune regulation, and protein synthesis. With a rising emphasis on nutrition-rich food and dietary supplementation, its application in nutritional products has surged—now accounting for nearly 30% of total consumption. This growing integration highlights the ingredient’s expanding relevance in health-focused consumer trends.

Rising Utilization in Pharmaceutical and Biotech Industries
The pharmaceutical and biotechnology sectors continue to significantly influence the market trajectory of L-histidine. Its utility in intravenous therapies, buffer solutions for biologics, and metabolic treatments has amplified its demand. Presently, pharmaceutical applications comprise around 35% of the global market share, driven by the compound’s versatility in drug formulations and disease management. Its use is further reinforced by ongoing medical research and its proven therapeutic efficacy.

Increased Demand from Sports Nutrition and Functional Foods
With health and wellness becoming top priorities for consumers, L-histidine is gaining momentum in sports nutrition and functional food segments. Known for aiding in muscle repair and reducing exercise-induced fatigue, it has become a popular inclusion in performance supplements. This niche is expanding at an annual growth rate of approximately 12%, reflecting a clear shift towards amino acid-based recovery and endurance products aimed at active lifestyles.

Innovation in Manufacturing Technologies
Technological progress in fermentation and amino acid production has played a crucial role in market expansion. Modern extraction and bioengineering techniques have enhanced both the efficiency and sustainability of L-histidine manufacturing. Notably, close to 40% of producers are transitioning to eco-friendly biotechnological methods, addressing growing consumer interest in natural and clean-label ingredients while also lowering production costs.

Supportive Research and Regulatory Developments
The favorable research landscape and regulatory support further strengthen the growth outlook for L-histidine. Emerging studies are investigating its potential benefits in neurological health, inflammation control, and metabolic disorders. With over 25% of nutritional clinical trials involving amino acid analysis, L-histidine continues to capture scientific and commercial interest. These combined factors are fostering a robust and optimistic market environment for the foreseeable future.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Grade
    3. Market Snapshot, By Source
    4. Market Snapshot, By Application
    5. Market Snapshot, By Distribution Channel
    6. Market Snapshot, By End Users
    7. Market Snapshot, By Region
  4. L-Histidine Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising demand in pharmaceutical formulations
        2. Increasing use in dietary supplements industry
        3. Growing application in animal feed nutrition
        4. Expanding role in metabolic disorder treatments
      2. Restraints
        1. High production and purification costs
        2. Limited raw material availability globally
        3. Stringent regulations on amino acid usage
        4. Low consumer awareness in developing regions
      3. Opportunities
        1. Advances in fermentation-based production methods
        2. Expansion into functional food and beverages
        3. Rising R&D in amino acid therapies
        4. Growth potential in emerging healthcare markets
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. L-Histidine Market, By Product Type, 2021 - 2031 (USD Million)
      1. Tablet
      2. Capsule
      3. Fluids
      4. Others
    2. L-Histidine Market, By Grade, 2021 - 2031 (USD Million)
      1. Pharmaceutical Grade
      2. Food Grade
      3. Feed Grade
    3. L-Histidine Market, By Source, 2021 - 2031 (USD Million)
      1. Fermentation-Based L-Histidine
      2. Synthetic L-Histidine
    4. L-Histidine Market, By Application, 2021 - 2031 (USD Million)

      1. Pharmaceutical Industry

      2. Biotechnological Industry

      3. Medical Industry

    5. L-Histidine Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Direct Tender
      2. Hospital Pharmacy
      3. Retail Pharmacy
      4. Online Pharmacy
      5. Others
    6. L-Histidine Market, By End Users, 2021 - 2031 (USD Million)

      1. Hospitals

      2. Specialty Clinics

      3. Ambulatory Surgical Centres

      4. Other

    7. L-Histidine Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Angene Chemicals
      2. Abi Chemicals
      3. Acron Pharma
      4. Ajinomoto Co. Inc.
      5. Changzhou Highassay Chemical Co. Ltd.
      6. Huaheng Biologgical
      7. Kyowa Hakko Bio Co. Ltd.
      8. My Protein
      9. Twin Labs
      10. Merck & Co. Inc.
      11. Novartis AG
      12. Hoffmann-La Roche Ltd
      13. Amgen Inc
      14. Eisai Co. Ltd.
      15. GlaxoSmithKline plc.
      16. Pfizer Inc
      17. Nordisk A/S
  7. Analyst Views
  8. Future Outlook of the Market